Mesothelioma Attorneys

NEW YORK, Feb. 9 /PRNewswire/ – The Doctor-Patient Alliance for Responsible Asbestos Policy today repeated its call on the U.S. Senate to cure fatal flaws in the proposed Asbestos Trust Fund bill (SB 852).

Last July, the nationwide group of 34 doctors who treat mesothelioma patients urged the U.S. Senate to remove the “one-size-fits-all” cap on awards and install a due process hearing, at which patients could prove their special medical and financial hardship damages and have their award tailored accordingly. The claims review system would be modeled after the 9/11 Victims Compensation Fund.

In addition, the Doctor-Patient Alliance asked for assurances that dying mesothelioma patients would be fairly compensated during their shortened life span. The detailed letter was sent to all 100 U.S. Senators.

“We are disappointed that our.

Source : accessmylibrary.com

A nurse who watched her father die of asbestos-related cancer today pleaded for more money and research to find a cure for the deadly disease.

Lifelong Devonport Dockyard worker Roger Lowe died in December at the age of 68, just six months after being diagnosed with mesothelioma - a rare form of cancer that is contracted after exposure to asbestos. It can lie dormant inside the body for decades.

Still coming to terms with the loss, daughter Jackie Lowe is now trying to.

Source : accessmylibrary.com

Rogue employers’ liability wordings may leave mesothelioma claimants in limbo, not knowing from which insurer they can claim year to year, an expert has warned.

Mark Burton, an associate at DLA Piper Rudnick Gray Cary said the problem was due to their resemblance…

Source : accessmylibrary.com

Malignant mesothelioma - a rare form of cancer - is a disease in which malignant cancer cells are found in the sac lining the chest, the lining of the abdominal cavity or the lining around the heart.

Most people with malignant mesothelioma have worked on jobs where they breathed asbestos.

Source : accessmylibrary.com

BLOOMFIELD, N.J., Jan. 27 /PRNewswire-FirstCall/ – Alfacell Corporation today announced the formation of a Thoracic Cancer Advisory Board to support the Company’s strategic focus on developing novel ribonuclease (RNase) therapies for the treatment of diseases such as mesothelioma and non-small cell lung cancer (NSCLC).

The Thoracic Cancer Advisory Board will work in coordination with the Company’s prestigious Scientific Advisory Board, led by Dr. David Sidransky, Director of Head and Neck Cancer Research at Johns Hopkins University, as well as with the Business Policy Committee, chaired by former U.S. Department of Health and Human Services Secretary Tommy G. Thompson.

“We are extremely pleased to have attracted such esteemed colleagues to the Alfacell Thoracic Cancer Advisory Board,” stated Kuslima Shogen, Chief Executive Officer of Alfacell. “All are highly-accomplished, internationally-renowned experts in oncology, and are universally recognized as thought leaders and pioneers in mesothelioma and lung cancer research. We look forward to collaborating with

Source : accessmylibrary.com

LOS ANGELES, Jan. 24 /PRNewswire/ – Twenty Five years ago, mesothelioma took the life of Hollywood legend Steve McQueen. To mark the anniversary of his death, asbestos trial lawyer Roger Worthington donated the fee paid by a Hollywood movie production company for the use of his home to mesothelioma medical research.

McQueen’s story is well known. After his diagnosis in Los Angeles in 1979, McQueen eschewed conventional therapies for untested nostrums in Mexico, such as laetrile, coffee enemas and cow fetus injections

Source : accessmylibrary.com

COPYRIGHT 2006 PR Newswire Association LLC

Billions Were Sold Over Five Decades

Victory For Nationally Known Mass Toxic Tort Firm, Levy Phillips & Konigsberg, LLP

Second Major Blow To Welding Industry In Nine Days

NEW YORK, Jan. 9 /PRNewswire/ – In the second major verdict against the U.S. welding industry in little more than a week, a New York State appeals court on Dec. 29th affirmed the first-ever jury finding that asbestos-containing welding rods, sold in the billions…

Source : accessmylibrary.com

W I’m also a pensioner and lived in my last street for 63 years before I moved home. One has to accept you cannot live in the past and have to accept change and move on.

Mrs Taylor has received a very generous offer from St Monica Trust. The quality of sheltered hous- ing is very high and a lot of pen- sioners would jump at the offer.

In a modern flat her quality of life would be better, much easier to manage and maintain, plus the social life these flats offer.

Decorating, heating and main- tenance bills are all going to be smaller. And I am sure the trust would make the move hassle-free for her, like including fitted carpets and such. Also, it would surely give her daughter peace of mind to know her mother was safe and cared for.

The comment made by Mrs Taylor that she wishes to pass the house on to her family when she dies is a fair one, except that, should she live 10 or more years, the development will be finished and the house would be worthless and impossible to sell.

It’s far better for her to sell now, get a going rate, have a little to help enjoy a few luxuries and give the money to her family. They will be left with a lot of hassle when she’s not here.

So I do have sympathy for Mrs Taylor but feel she should give it a lot of thought.

Janet Peacock (Mrs), Bristol.

Wind farm - no, nuclear power - yes SO the good citizens of Brent Knoll and Burnham are objecting to an eco-friendly wind farm in their

Source : accessmylibrary.com

Plymouth remains a hotspot for asbestos-related deaths, according to new Government figures.

Statistics for the Department for Work and Pensions (DWP) reveal that 86 people in the city died from mesothelioma - a cancer strongly associated with exposure to asbestos - in the five years to 2003.

This is more than three times the number in nearby Torbay, where there were 24 deaths, and just two fewer than for the whole of Cornwall and the Isles…

Source : accessmylibrary.com

Mesotheliom–a potent and usually deadly cancer that has been linked to asbestos exposure but that takes decades to develop–is the subject of increasing legal action, with dozens of law firms actively seeking plaintiffs to file suit against the companies that may have been responsible for their asbestos exposure. In fact, hundreds of thousands of injury claims, including many for mesothelioma, have pushed approximately 80 companies into bankruptcy. But it can be difficult to differentiate mesothelioma from other cancers–which can make treatment difficult, let alone litigation. To that end, researchers and clinicians have over the past five years looked carefully at what pathologic studies to undertake when a diagnosis of mesothelioma is suspected. This article will focus on that research.

Asbestos is a type of insulation material that was used widely in the past in the construction, ship building, automotive, and other manufacturing industries. The material is crystalline, and can splinter into tiny chards or dust particles. When these fibers have been breathed in, they travel through the respiratory path and can become lodged within the airways. The smaller fibers are able to travel to the ends of the small air passages and reach the pleura. The tiny bits of mineral cause physical damage to the mesothelial cells. The asbestos fibers irritate the mesothelial cells and this seems to trigger the healthy cells to begin reproducing, and a cancerous situation is created. In addition, the asbestos fibers cause injury to cells, which can result in lung cancer and/or asbestosis, which is the condition where healthy lung tissue is replaced by scar tissue. If swallowed, these fibers can reach the abdominal cavity where they have a role in causing peritoneal mesothelioma. (1)

There are three commonly used types of asbestos: white, brown, and blue. Brown and blue asbestos are most commonly associated with mesothelioma. The use of asbestos was very widespread after 1945, but the first symptoms of mesothelioma may not become apparent until 10 to 40 years after the initial exposure–which makes the disease very difficult to diagnose. Some studies have estimated that the peak in mesothelioma cases will be reached in 2010. (2) Peak use of asbestos was in the 1970s. Currently, epidemiologists estimate that around 3,000 Americans die each year from malignant mesothelioma, and another 7,000 from other cancers and conditions associated with asbestos exposure. Between 1979 and 2001, there were at least 43,000 deaths from mesothelioma. Advocates for mesothelioma patients say that this number is probably low, because mesothelioma often was misdiagnosed and only was tracked as a cause of death beginning in 1999. One study concluded that the disease may already have peaked in the United States, but other sources predict that mesothelioma deaths will peak in 2016 in the United States. This peak is expected to occur later in countries such as the United Kingdom and Australia, which regulated asbestos use later than in the United States. Malignant mesothelioma affects three times as many men as it does women. (3)

More : accessmylibrary.com